HRP20090675T1 - Postupak dobivanja međuprodukata epoksibutanola - Google Patents

Postupak dobivanja međuprodukata epoksibutanola Download PDF

Info

Publication number
HRP20090675T1
HRP20090675T1 HR20090675T HRP20090675T HRP20090675T1 HR P20090675 T1 HRP20090675 T1 HR P20090675T1 HR 20090675 T HR20090675 T HR 20090675T HR P20090675 T HRP20090675 T HR P20090675T HR P20090675 T1 HRP20090675 T1 HR P20090675T1
Authority
HR
Croatia
Prior art keywords
formula
compound
image
hal
same meaning
Prior art date
Application number
HR20090675T
Other languages
English (en)
Croatian (hr)
Inventor
Muller Marc
Xu Lin
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of HRP20090675T1 publication Critical patent/HRP20090675T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
HR20090675T 2005-12-01 2006-11-29 Postupak dobivanja međuprodukata epoksibutanola HRP20090675T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05026163 2005-12-01
PCT/CH2006/000671 WO2007062542A2 (en) 2005-12-01 2006-11-29 Process for the manufacture of epoxybutanol intermediates

Publications (1)

Publication Number Publication Date
HRP20090675T1 true HRP20090675T1 (hr) 2010-01-31

Family

ID=36178579

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090675T HRP20090675T1 (hr) 2005-12-01 2006-11-29 Postupak dobivanja međuprodukata epoksibutanola

Country Status (19)

Country Link
US (2) US7816537B2 (https=)
EP (2) EP2133345A1 (https=)
JP (1) JP5329969B2 (https=)
KR (1) KR101191682B1 (https=)
CN (1) CN101321522B (https=)
AT (1) ATE444747T1 (https=)
AU (2) AU2006319657B2 (https=)
BR (1) BRPI0619120B1 (https=)
CA (2) CA2711852C (https=)
CY (1) CY1110588T1 (https=)
DE (1) DE602006009698D1 (https=)
DK (1) DK1954264T3 (https=)
ES (1) ES2333258T3 (https=)
HR (1) HRP20090675T1 (https=)
PL (1) PL1954264T3 (https=)
PT (1) PT1954264E (https=)
SI (1) SI1954264T1 (https=)
WO (1) WO2007062542A2 (https=)
ZA (1) ZA200804218B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012003126A (es) 2009-09-21 2012-06-19 Gilead Sciences Inc Procesos e intermedios para la preparacion de analogos de 1'-carbonucleosidos sustituidos.
ES2524356T3 (es) 2010-07-22 2014-12-05 Gilead Sciences, Inc. Métodos y compuestos para tratar infecciones provocadas por virus Paramyxoviridae
CA2878361C (en) 2012-08-07 2020-09-22 Basilea Pharmaceutica Ag Process for the manufacture of isavuconazole or ravuconazole
WO2015150947A1 (en) 2014-03-29 2015-10-08 Wockhardt Limited A process for the preparation of isavuconazole and its intermediates
TWI687432B (zh) 2014-10-29 2020-03-11 美商基利科學股份有限公司 絲狀病毒科病毒感染之治療
DK3785717T3 (da) 2015-09-16 2022-03-21 Gilead Sciences Inc Fremgangsmåder til behandling af coronaviridae-infektioner
CN105367528A (zh) * 2015-11-10 2016-03-02 南通诺泰生物医药技术有限公司 一种三唑类药物中间体(d)-1-(1-环烷仲胺基)-2-(2-四氢吡喃基)氧-1-丙酮类化合物及合成方法
US10682368B2 (en) 2017-03-14 2020-06-16 Gilead Sciences, Inc. Methods of treating feline coronavirus infections
CA3059777C (en) 2017-05-01 2023-02-21 Gilead Sciences, Inc. Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
WO2019014247A1 (en) 2017-07-11 2019-01-17 Gilead Sciences, Inc. COMPOSITIONS COMPRISING POLYMERASE RNA INHIBITOR AND CYCLODEXTRIN FOR THE TREATMENT OF VIRAL INFECTIONS
CN110997646B (zh) 2017-08-10 2023-06-20 住友化学株式会社 环氧醇化合物的制造方法
JP2023512656A (ja) 2020-01-27 2023-03-28 ギリアード サイエンシーズ， インコーポレイテッド ＳＡＲＳ ＣｏＶ－２感染を治療するための方法
KR20220153619A (ko) 2020-03-12 2022-11-18 길리애드 사이언시즈, 인코포레이티드 1'-시아노 뉴클레오사이드의 제조 방법
CA3172483A1 (en) 2020-04-06 2021-10-14 Scott Ellis Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
TW202203941A (zh) 2020-05-29 2022-02-01 美商基利科學股份有限公司 瑞德西韋之治療方法
PE20230618A1 (es) 2020-06-24 2023-04-14 Gilead Sciences Inc Analogos de nucleosido de 1'-ciano y usos de los mismos
IL300453A (en) 2020-08-27 2023-04-01 Gilead Sciences Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
KR20240154647A (ko) 2022-03-02 2024-10-25 길리애드 사이언시즈, 인코포레이티드 바이러스성 감염 치료를 위한 화합물 및 방법
US12357577B1 (en) 2024-02-02 2025-07-15 Gilead Sciences, Inc. Pharmaceutical formulations and uses thereof
CN115536643A (zh) * 2022-12-05 2022-12-30 南京桦冠生物技术有限公司 一种艾沙康唑类药物关键中间体的制备方法
CN119264078B (zh) * 2024-12-09 2025-08-01 浙江世佳科技股份有限公司 一种(5s,6r)-5,6-环氧-2-十七碳炔-1-醇的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3452213B2 (ja) * 1994-07-05 2003-09-29 エーザイ株式会社 抗真菌剤及びその製造方法
AU2931399A (en) * 1998-03-06 1999-09-20 F. Hoffmann-La Roche Ag 3-(4-(4-cyanophenyl)thiazol-2-y))-1-(1h-1,2,4-triazol-1-yl) -butan-2-ol derivatives having antifungal activity
US6133485A (en) * 1998-04-15 2000-10-17 Synphar Laboratories, Inc. Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
US6391903B1 (en) * 1999-09-09 2002-05-21 Sankyo Company, Limited Triazole derivatives having antifungal activity
US6884892B2 (en) 2002-06-20 2005-04-26 Sumitomo Chemical Company, Limited Production methods of epoxytriazole derivative and intermediate therefor
JP4627413B2 (ja) * 2003-05-06 2011-02-09 三井化学株式会社 １−アゾール−２−フェニル−２、３−プロパンジオール誘導体の製造法

Also Published As

Publication number Publication date
AU2010203301B2 (en) 2012-06-21
WO2007062542A2 (en) 2007-06-07
KR20080075014A (ko) 2008-08-13
CY1110588T1 (el) 2015-04-29
AU2010203301A1 (en) 2010-08-12
ES2333258T3 (es) 2010-02-18
PL1954264T3 (pl) 2010-02-26
CA2629092C (en) 2012-01-03
BRPI0619120A2 (pt) 2011-09-13
CA2711852A1 (en) 2007-06-07
DE602006009698D1 (de) 2009-11-19
JP2009517413A (ja) 2009-04-30
CN101321522B (zh) 2012-05-30
AU2006319657B2 (en) 2010-08-12
EP1954264B1 (en) 2009-10-07
JP5329969B2 (ja) 2013-10-30
WO2007062542A3 (en) 2007-11-01
ATE444747T1 (de) 2009-10-15
US20110021794A1 (en) 2011-01-27
BRPI0619120B1 (pt) 2023-10-10
DK1954264T3 (da) 2010-01-11
CA2629092A1 (en) 2007-06-07
CA2711852C (en) 2011-10-04
CN101321522A (zh) 2008-12-10
US8076494B2 (en) 2011-12-13
EP2133345A1 (en) 2009-12-16
US7816537B2 (en) 2010-10-19
EP1954264A2 (en) 2008-08-13
ZA200804218B (en) 2009-01-28
AU2006319657A1 (en) 2007-06-07
SI1954264T1 (sl) 2010-01-29
KR101191682B1 (ko) 2012-10-16
US20090299073A1 (en) 2009-12-03
PT1954264E (pt) 2009-12-23

Similar Documents

Publication Publication Date Title
HRP20090675T1 (hr) Postupak dobivanja međuprodukata epoksibutanola
NO20110366L (no) Forbindelser og prosesser
RU2010141941A (ru) Способ получения фторсодержащего производного ацилуксусной кислоты, способ получения фторсодержащего производного сложного эфира пиразолкарбоновой кислоты и способ получения фторсодержащего пиразолкарбоновой кислоты
RU2012134783A (ru) Способ получения солей тетразолметансульфоновой кислоты и новое соединение, используемое в нем
YU45667B (sh) Postupak za dobijanje 1,2,4-triazolon jedinjenja
HRP20250284T1 (hr) Postupak dobivanja tetracikličkog spoja
JP2014037370A (ja) チオフェン環を有するイミダゾール化合物
CA3009592A1 (en) Process for preparing 1,1,3-trioxo-1,2-benzothiazole-6-carboxamide
SU541430A3 (ru) Способ получени з-аминопиразолонов-5 или их солей
EP3812369B1 (en) A bromination method for m-diamide compounds
IL185884A (en) A method for making converted pyrimidines
BR112016010413B1 (pt) processo para preparação de derivados de 3,5-bis(haloalquil)pirazole a partir de a,a-dihaloaminas
ES2759795T3 (es) Nuevo método para la preparación de un compuesto de tienopirimidina e intermedios usados en el mismo
RU2003116520A (ru) Способ и сложноэфирные производные, используемые для получения цефалоспоринов
US2621162A (en) J-propargyl-x-quinazolones and acid
DE10012825A1 (de) Verfahren zur Herstellung von spirocyclischen Tetronsäurederivaten
US3322828A (en) Trifluoromethyl-sulphonic acid-trifluoromethylphenyl amides and process for their production
PT1286939E (pt) Metodo para a fluorometilacao de alcoois por meio de descarboxilacao halogenativa
PL94736B1 (pl) Sposob wytwarzania 2-triazolo(3,4-b)-benzotiazoli
JP2589929B2 (ja) メチル ３−クロロ−１，１，２，２，３，３−ヘキサフルオロプロピル エーテル及びその製造方法
Tanaka et al. N-Acyl-1-chloro-2, 2, 2-trifluoroethylamine as a 2, 2, 2-Trifluoroethylamine-Building Block.
JP5260357B2 (ja) ２−（２，４−ジクロロベンジル）−４−フェニル−５−アルキルイミダゾール化合物
OZAKI et al. Studies on 4 (1H)-Quinazolinones. I. A Convenient Synthesis and Some Reactions of 1-Phenyl-2-substituted-4 (1H)-quinazolinones
Reddy et al. Synthesis and characterization of 6‐alkylcarbamato‐2, 10‐dichlorodibenzo [d, g][1, 3, 6, 2] dioxathiaphosphocin 6‐oxides
JP2010070479A (ja) ４−アリール−２−（１−ナフチルメチル）イミダゾール化合物